Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

OtherBRAIN

Neuro-Behcet’s Disease: Diffusion MR Imaging and Proton MR Spectroscopy

R. Nuri Sener
American Journal of Neuroradiology September 2003, 24 (8) 1612-1614;
R. Nuri Sener
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

Summary: We herein report the case of a 53-year-old woman with Behcet’s disease and an acute T2-hyperintense lesion in left side of the pons. Echo-planar “trace” diffusion MR imaging revealed high signal intensity changes at the lesion site on b = 1000 s/mm2 images, initially suggesting restricted diffusion. On corresponding apparent diffusion coefficient maps, however, the lesion had high signal intensity and high apparent diffusion coefficient values (1.22 × 10−3 mm2/s), compared with the contralateral normal side of the pons (0.86 × 10−3 mm2/s) and compared with the normal temporal white matter (0.80 × 10−3 mm2/s). This was consistent with the presence of increased diffusion, hence vasogenic edema. Proton MR spectroscopy excluded acute infarction. This particular pattern (high signal intensity on b = 1000 s/mm2 images in association with high apparent diffusion coefficient values) likely represented the acute inflammatory process associated with disrupted brain-blood barrier in the fulminant form of neuro-Behcet’s disease. Follow-up examinations ≤2 years later revealed a remaining gliotic lesion.

Behcet’s disease involves the CNS in approximately 5% to 10% of cases. The brain stem is the most common location of involvement (1, 2). Two recently published articles (3, 4) dealt with diffusion MR imaging findings of the disease, but no proton MR spectroscopy report is available. We herein present the report of a patient who was studied and followed up with these techniques.

Case Report

The patient was a 53-year-old woman with known Behcet’s disease diagnosed 12 years before her presentation to the hospital with acute right-sided hemiparesis. An MR imaging study was performed with a 1.5-T MR imaging unit. T2-weighted and fluid-attenuated inversion recovery images revealed a left-sided hyperintense lesion in the pons (Fig 1A). On T1-weighted images, there was a focal high signal intensity change within the lesion, suggesting hemorrhage or presence of myelin breakdown products (Fig 1B). T1-weighted images obtained after the IV administration of paramagnetic contrast medium revealed enhancement in the corresponding region (Fig 1C). Diffusion MR imaging was obtained with the echo-planar “trace” protocol (5700/139 [TR/TE]). On b = 1000 s/mm2 images, high signal intensity changes were evident at the lesion site in the left side of the pons, initially suggesting restricted diffusion (Fig 1D). On corresponding apparent diffusion coefficient (ADC) maps, however, this had high signal intensity and high ADC values (1.22 × 10−3 mm2/s), compared with the contralateral normal side of the pons (0.86 × 10−3 mm2/s) and compared with the temporal white matter (0.80 × 10−3 mm2/s). This was consistent with the presence of increased diffusion, hence vasogenic edema (Fig 1E). Proton MR spectroscopy (1500/40) of the lesion site revealed no lactic acid peak, presumably excluding acute infarct (Fig 1F). The major peaks—N-acetylaspartate, choline, and creatine—were normal. The clinical condition of the patient improved dramatically with IV administration of steroid treatment.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Images obtained during the acute stage.

A, Fluid-attenuated inversion recovery image reveals a left-sided hyperintense lesion in the pons.

B, T1-weighted image reveals a focal high signal intensity change, suggesting hemorrhage or presence of myelin breakdown products.

C, Contrast-enhanced T1-weighted image shows enhancement in the corresponding region.

D, Diffusion-weighted (b = 1000 s/mm2) image reveals high signal intensity in the lesion, suggesting restricted diffusion (see E).

E, ADC map (same section as that shown in D) reveals high signal intensity and a high ADC value (1.22 × 10−3 mm2/s), compared with the normal side of the pons (0.86 × 10−3 mm2/s) and compared with the temporal white matter (0.80 × 10−3 mm2/s). This is consistent with presence of increased diffusion, hence vasogenic edema.

F, Proton MR spectroscopy (1500/40) reveals that there is no lactic acid peak, excluding acute infarct. Major peaks are normal.

The patient was reexamined at this institution 16 months later. T2-weighted images revealed a markedly smaller focus of hyperintensity at the original lesion site in the left part of the pons (Fig 2A). For diffusion MR imaging, the three-gradient protocol (4000/110) was used. The b = 1000 s/mm2 image appeared normal (Fig 2B), whereas the ADC map revealed high signal intensity and a high ADC value (1.20 × 10−3 mm2/s), suggesting presence of gliosis at this stage of the disease (Fig 2C). Another study of the patient was available 9 months later (2 years after initial examination). The fluid-attenuated inversion recovery images from that study revealed similar sequelae changes, further suggesting presence of gliosis (Fig 3).

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Images obtained at the 16-month follow-up examination.

A, T2-weighted image reveals a small remaining focus of gliosis.

B, Diffusion-weighted (b = 1000 s/mm2) image is normal appearing.

C, ADC map (same section as that shown in B) reveals high signal intensity and a high ADC value (1.20 × 10−3 mm2/s), consistent with tissue disintegration due to gliosis.

Fig 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 3.

Fluid-attenuated inversion recovery image obtained at the 2-year follow-up examination reveals focal high signal intensity secondary to presumed gliosis.

Discussion

Behcet’s disease is a multisystemic inflammatory disorder with relapsing courses. Two main patterns of CNS involvement occur: parenchymal and nonparenchymal. The neuropathology of the parenchymal form is that of multifocal necrotizing lesions with marked inflammatory cell reactions, secondary to vasculitis, mainly with venular involvement. Brain stem is the most common location of involvement in this form. On the other hand, the nonparenchymal form is associated with lesions secondary to dural sinus thrombosis. In the CNS during the acute phase of neurologic manifestations of Behcet’s disease, MR imaging shows hyperintense lesions on T2-weighted sequences. The lesions usually reveal contrast enhancement. This MR imaging profile may be indistinguishable from that of granulomatous inflammations, acute disseminated encephalomyelitis, and some infections. Brain stem is the most common location of involvement, and basal ganglia, cerebral hemispheres, and spinal cord are the next most common (1, 2). The MR imaging findings for the current patient were consistent with those presented in previous reports (Fig 1A–C).

Two previous reports (3, 4) dealt with diffusion MR imaging in Behcet’s disease. Ohta et al (3) reported the cases of two patients for whom T2-weighted sequences revealed hyperintense brain stem changes whereas diffusion MR imaging (images corresponding to b = 1000 s/mm2) revealed isointensity. They concluded that this profile excluded cerebral infarction, because no high signal intensity was seen on diffusion MR images (3). In another article, Kang et al (4) reported a patient with brain stem, basal ganglion, thalamus, and corona radiata involvement in whom b = 1000 s/mm2 images and ADC maps were studied. They cited that b = 1000 s/mm2 images revealed slight hyperintensities whereas ADC values were high, ranging between 1.17 and 1.26 × 10−3 mm2/s, compared with normal ADC values of 0.77 to 0.80 × 10−3 mm2/s from the contralateral hemispheres (4). They commented that the ADC values in the lesions were consistent with high diffusion rates, indicating vasogenic edema. It is cited that vasogenic edema develops when the blood-brain barrier is disrupted and is not primarily associated with cellular damage (4). A pathologic report of the fulminant form of Behcet’s disease found an acute destructive inflammatory process without evidence of vasculitis (5). The occurrence of acute lesions in the disease has been attributed to reversible breakdown in the blood-brain barrier associated with vasogenic edema (4–6). The diffusion MR imaging findings for our patient during the acute stage, consisting of high signal intensity brain stem changes on b = 1000 s/mm2 images (Fig 1D) and high signal intensity and high ADC values (1.22 × 10−3 mm2/s) compared with the contralateral normal side of the pons (0.86 × 10−3 mm2/s) and compared with the temporal white matter (0.80 × 10−3 mm2/s) (Fig 1E), were similar to the findings presented by Kang et al (4). We also consider this pattern to be a reflection of vasogenic edema associated with disrupted blood-brain barrier. Regarding discrimination of vasogenic from cytotoxic edema by diffusion MR imaging, it is known that cytotoxic edema usually reveals high signal intensity on b = 1000 s/mm2 images (with low signal intensity and low ADC values) whereas in cases of vasogenic edema, b = 1000 s/mm2 images are usually normal appearing in association with high signal intensity and high ADC values (3, 4). For the current patient with fulminant Behcet’s disease, however, b = 1000 s/mm2 images exhibited high signal intensity and, at the same time, ADC values were high. Kang et al (4) experienced similar findings. Therefore, we suggest that this particular diffusion MR imaging pattern may be a reflection of the acute inflammatory process in Behcet’s disease. In addition to diffusion MR imaging, we performed proton MR spectroscopy at the lesion site, which revealed no lactic acid peak; the major peaks were normal (Fig 1F). This presumably excluded the possibility of acute infarct, further supporting the suggestions regarding diffusion MR imaging and vasogenic edema. No previous proton MR spectroscopy report has specifically dealt with brain stem infarctions. However, those involving acute infarction in general cite that after an infarct, lactate appears and NAA and total creatine are reduced compared with the unaffected brain tissue (7).

Histopathology during the chronic stage of Behcet’s disease mainly consists of longstanding inflammatory changes and gliosis. For the patient whose case is reported herein, the main MR imaging finding at the 16-month follow-up examination was that of remaining gliosis on T2-weighted images (Fig 2A), which was unchanged 9 months later, as shown by the third examination (Fig 3). Diffusion MR imaging at the 16-month follow-up examination consisted of a normal b = 1000 s/mm2 image with a high ADC value (1.20 × 10−3 mm2/s) for the remaining lesion. This high ADC value was likely representative of disintegrated tissue due to gliosis (Fig 2C).

References

  1. ↵
    Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet’s disease: evaluation of 200 patients: The Neuro-Behcet Study Group. Brain 1999;122:2171–2182
    Abstract/FREE Full Text
  2. ↵
    Kocer N, Islak C, Siva A, et al. CNS involvement in neuro-Behcet syndrome: an MR study. AJNR Am J Neuroradiol 1999;20:1015–1024
    Abstract/FREE Full Text
  3. ↵
    Ohta K, Obara K, Sato H, Iguchi T, Suzuki N. Diffusion-weighted magnetic resonance imaging of neuro-Behcet’s disease [in Japanese]. Rinsho Shinkeigaku 2000;40:398–401
    PubMed
  4. ↵
    Kang DW, Chu K, Cho JY, et al. Diffusion weighted magnetic resonance imaging in neuro-Behcet’s disease. J Neurol Neurosurg Psychiatry 2001;70:412–413
    FREE Full Text
  5. ↵
    Hadfield MG, Aydin F, Lippman HR, Sanders KM. Neuro-Behcet’s disease. Clin Neuropathol 1997;16:55–60
    PubMed
  6. ↵
    Patel DV, Neuman MJ, Hier DB. Reversibility of CT and MR findings in neuro-Behcet disease. J Comput Assist Tomogr 1989;13:669–673
    PubMed
  7. ↵
    Saunders DE. MR spectroscopy in stroke. Br Med Bull 2000;56:334–345
    Abstract/FREE Full Text
  • Received January 27, 2003.
  • Accepted after revision March 28, 2003.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 24 (8)
American Journal of Neuroradiology
Vol. 24, Issue 8
1 Sep 2003
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neuro-Behcet’s Disease: Diffusion MR Imaging and Proton MR Spectroscopy
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
R. Nuri Sener
Neuro-Behcet’s Disease: Diffusion MR Imaging and Proton MR Spectroscopy
American Journal of Neuroradiology Sep 2003, 24 (8) 1612-1614;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Neuro-Behcet’s Disease: Diffusion MR Imaging and Proton MR Spectroscopy
R. Nuri Sener
American Journal of Neuroradiology Sep 2003, 24 (8) 1612-1614;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Neurological involvement by Behcets syndrome: clinical features, diagnosis, treatment and outcome
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
  • Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study
  • SWI or T2*: Which MRI Sequence to Use in the Detection of Cerebral Microbleeds? The Karolinska Imaging Dementia Study
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire